Managers

Intel

Icahn launches Illumina proxy battle

Icahn launches Illumina proxy battle

Activist investor Carl Icahn is preparing to launch a proxy fight at Illumina, seeking three board seats, prompted by the biotech company's $8 billion acquisition of cancer screening start-up Grail, which Icahn says is now costing the company $800 million per year, according to reports.

Intel

Neuberger Berman cuts Blackstone stake

Neuberger Berman cuts Blackstone stake

A recent Form 13F filing made with the US Securities & Exchange Commission has revealed the Neuberger Berman Group reduced its stake in Blackstone Inc by 12.1% to 4,625,456 shares in the third quarter after selling 634,353 shares during the period, according to a report by MarketBeat.